[MeMed in Business Wire] MeMed completes development of first-ever fingerstick host-response test for rapid differentiation of bacterial and viral infections

ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)–MeMed, a global leader in host-response diagnostics, today announced the completion of its multi-year development of MeMed BV Flex, an innovative, next-generation test designed to expand the reach of MeMed BV^® into decentralized, CLIA-waived settings. The test enables accurate differentiation between bacterial and viral infections in just 15 minutes using only a few drops of capillary blood from a finger prick.

Read more here.